- TMDX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-8 Filing
TransMedics (TMDX) S-8Registration of securities for employees
Filed: 4 Aug 23, 4:43pm
As filed with the Securities and Exchange Commission on August 4, 2023
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
TRANSMEDICS GROUP, INC.
(Exact name of registrant as specified in its charter)
Massachusetts
(State or other jurisdiction of incorporation or organization)
83-2181531
(IRS Employer Identification No.)
200 Minuteman Road
Andover, Massachusetts 01810
(Address of Principal Executive Offices) (Zip Code)
TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan
(Full title of the plan)
Waleed H. Hassanein, M.D.
President and Chief Executive Officer
TransMedics Group, Inc.
200 Minuteman Road
Andover, Massachusetts 01810
(Name and address of agent for service)
(978) 552-0900
(Telephone number, including area code, of agent for service)
Copies to:
Tara Fisher
Ropes & Gray LLP
Prudential Tower
800 Boylston Street
Boston, MA 02199-3600
(617) 951-7000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☒ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
Statement of Incorporation by Reference
This Registration Statement on Form S-8, relating to the Amended and Restated 2019 Stock Incentive Plan of TransMedics Group, Inc. (the “Registrant”), is being filed for the purpose of registering additional securities of the same class as other securities for which a Registration Statement on Form S-8 has previously been filed and is effective. The Registrant increased the number of shares of its common stock, no par value per share (“Common Stock”) available for issuance under its Amended and Restated 2019 Stock Incentive Plan by 1,000,000 shares. Pursuant to General Instruction E to Form S-8, this Registration Statement incorporates by reference the contents of the Registration Statement on Form S-8 (File No. 333-231243) filed with the Securities and Exchange Commission on May 6, 2019 by the Registrant, relating to the Registrant’s 2019 Stock Incentive Plan, except to the extent supplemented, amended or superseded by the information set forth herein.
Item 8. Exhibits.
EXHIBIT INDEX
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Andover, Commonwealth of Massachusetts, on this 4th day of August, 2023.
TRANSMEDICS GROUP, INC. | ||
By: | /s/ Waleed H. Hassanein, M.D. | |
Name: Title: | Waleed H. Hassanein, M.D. President, Chief Executive Officer and Director |
POWER OF ATTORNEY
Each person whose signature appears below constitutes and appoints Waleed H. Hassanein, M.D. and Stephen Gordon, and each of them acting individually, his or her true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8 to be filed by TransMedics Group, Inc., and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitutes, may lawfully do or cause to be done by virtue hereof.
* * * *
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature | Title | Date | ||
/s/ Waleed H. Hassanein, M.D. Waleed H. Hassanein, M.D. | President, Chief Executive Officer and Director (Principal Executive Officer) | August 4, 2023 | ||
/s/ Stephen Gordon Stephen Gordon | Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) | August 4, 2023 | ||
/s/ James R. Tobin James R. Tobin | Chairman of the Board | August 4, 2023 | ||
/s/ Edward M. Basile Edward M. Basile | Director | August 4, 2023 | ||
/s/ Thomas J. Gunderson Thomas J. Gunderson | Director | August 4, 2023 | ||
/s/ Edwin M. Kania, Jr. Edwin M. Kania, Jr. | Director | August 4, 2023 | ||
/s/ Stephanie Lovell Stephanie Lovell | Director | August 4, 2023 | ||
/s/ Merilee Raines Merilee Raines | Director | August 4, 2023 | ||
/s/ David Weill, M.D. David Weill, M.D. | Director | August 4, 2023 |